Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aprea Therapeutics Inc
(NQ:
APRE
)
5.350
-0.100 (-1.83%)
Streaming Delayed Price
Updated: 3:10 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aprea Therapeutics Inc
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 22, 2022
Via
Benzinga
Aprea Therapeutics: Q2 Earnings Insights
August 12, 2022
Aprea Therapeutics (NASDAQ:APRE) reported its Q2 earnings results on Friday, August 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Aprea Therapeutics posted...
Via
Benzinga
This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session
July 19, 2022
Gainers Applied Blockchain, Inc. (NASDAQ: APLD) jumped 50.1% to $1.5907 after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue...
Via
Benzinga
Recap: Aprea Therapeutics Q1 Earnings
May 16, 2022
Aprea Therapeutics (NASDAQ:APRE) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 18, 2022
Via
Benzinga
Short Volatility Alert: Aprea Therapeutics, Inc.
July 13, 2022
On Tuesday, shares of Aprea Therapeutics, Inc. (NASDAQ: APRE) experienced volatile short activity. After the activity, the stock price went up +5.14% to $0.94. The overall sentiment for APRE has been...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Via
Benzinga
Aprea Therapeutics (APRE) Stock Soars as Wedbush Sets $3 Price Target
July 08, 2022
Wedbush analyst Robert Driscoll just gave a huge upside target for APRE stock. Here’s why this is significant for the biotech sector.
Via
InvestorPlace
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
July 08, 2022
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100.
Via
Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022
July 08, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 08, 2022
Via
Benzinga
Twitter And 20 Stocks Moving Premarket
July 08, 2022
Gainers Seritage Growth Properties (NYSE: SRG) rose 35.7% to $8.25 in pre-market trading after gaining around 10% on Thursday. Seritage Growth Properties filed its preliminary proxy materials with the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 07, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 30, 2022
Gainers
Via
Benzinga
88 Biggest Movers From Yesterday
May 27, 2022
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 25, 2022
Via
Benzinga
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
FDA Lifts Clinical Hold On Aprea's Relapsed/Refractory Blood Cancer Studies
March 16, 2022
Aprea Therapeutics Inc (NASDAQ: APRE) can resume testing its eprenetapopt after a string of clinical holds on the therapy in August 2021. The Company plans to study the drug in new trials across...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
March 16, 2022
Stifel cut the price target on Adobe Inc. (NASDAQ: ADBE) from $700 to $600. Adobe shares rose 1.9% to $429.50 in pre-market trading.
Via
Benzinga
81 Biggest Movers From Yesterday
May 18, 2022
Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.
Via
Benzinga
40 Stocks Moving In Monday's Mid-Day Session
December 13, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 17, 2022
On Tuesday, 123 stocks made new 52-week lows.
Via
Benzinga
73 Biggest Movers From Yesterday
May 17, 2022
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.
Via
Benzinga
FDA Lifts Clinical Hold On Aprea's Eprenetapopt Trial In Myeloid Malignancies
December 09, 2021
The FDA removed the full clinical hold on Aprea Therapeutics Inc's (NASDAQ: APRE) trial evaluating the combination of eprenetapopt, with acalabrutinib or...
Via
Benzinga
Exposures
Product Safety
58 Biggest Movers From Yesterday
December 14, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 09, 2021
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
Exposures
Product Safety
You Ask, We Analyze: The Bull, Bear Case For Camber Energy And Aprea Stocks
October 07, 2021
On Wednesday evening, Benzinga asked its Benzinga Pro community which tickers they’d like analyzed. From the replies Benzinga selected these two tickers for technical...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 29, 2021
Gainers Regencell Bioscience (NASDAQ:RGC)...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.